cardiology careers collections past issues search home
     

J Am Coll Cardiol, 2005; 45:910-914, doi:10.1016/j.jacc.2004.11.056
© 2005 by the American College of Cardiology Foundation
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (4)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wolk, R.
Right arrow Articles by Somers, V. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wolk, R.
Right arrow Articles by Somers, V. K.

CLINICAL RESEARCH: CARDIOVASCULAR EFFECTS OF TOBACCO

Hemodynamic and autonomic effects of smokeless tobacco in healthy young men

Robert Wolk, MD, PhD*, Abu S.M. Shamsuzzaman, MBBS, PhD*, Anna Svatikova, BA*, Christine M. Huyber*, Corey Huck, BA*, Krzysztof Narkiewicz, MD, PhD{dagger} and Virend K. Somers, MD, PhD, FACC*,*

* Mayo Clinic, Rochester, Minnesota
{dagger} Medical University of Gdansk, Gdansk, Poland

Manuscript received July 16, 2004; revised manuscript received November 17, 2004, accepted November 29, 2004.

* Reprint requests and correspondence: Dr. Virend K. Somers, Mayo Clinic, DO-4-350, 1216 Second Street SW, Rochester, Minnesota 55902 (Email: somers.virend{at}mayo.edu).

OBJECTIVES: The aim of this study was to investigate the acute hemodynamic and autonomic effects of smokeless tobacco.

BACKGROUND: Smokeless tobacco use is increasing. Its cardiovascular effects are not well understood.

METHODS: Sixteen healthy, male, habitual snuff tobacco users (aged 22 ± 1 year) were studied, using a randomized, double-blind, placebo-controlled, crossover design with two separate experimental sessions: placebo and tobacco. Muscle sympathetic nerve activity (MSNA), electrocardiogram, blood pressure, calf blood flow, nicotine, and catecholamines were measured.

RESULTS: Snuff tobacco increased plasma nicotine from 2.8 ± 0.5 ng/ml to 10.4 ± 1.1 ng/ml. Mean blood pressure increased by 10 ± 1 mm Hg, and heart rate increased by 16 ± 2 beats/min. Peripheral vascular resistance, MSNA, and norepinephrine concentration did not change with tobacco, but epinephrine increased by ~50%.

CONCLUSIONS: Oral snuff tobacco increases heart rate, blood pressure, and epinephrine. Despite the increase in blood pressure, there is no decrease in either MSNA or peripheral vascular resistance. Smokeless tobacco is a powerful autonomic and hemodynamic stimulus. Catecholamine release from the adrenal medulla likely contributes to this response.

Abbreviations and Acronyms
  BP = blood pressure
  HR = heart rate
  MSNA = muscle sympathetic nerve activity




This article has been cited by other articles:


Home page
Int J EpidemiolHome page
P. N Lee
Circulatory disease and smokeless tobacco in Western populations: a review of the evidence
Int. J. Epidemiol., August 1, 2007; 36(4): 789 - 804.
[Abstract] [Full Text] [PDF]



 
  cardiology careers collections past issues search home